Financials

  • Market Capitalization 460.18 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
2.4
ratio cours/chiffre d'affaires
2.05

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2947
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
16.55 USD+12.13%+4.88%+185.84%-2.65%470.40 M USD
2956
CCCC
C4 Therapeutics, Inc. - Common Stock
3.78 USD+1.89%-9.79%+8.31%+47.08%465.04 M USD
2980
AGMB
AgomAb Therapeutics NV - ADRs representing one
13.17 USD0.00%-2.44%+4.28%-10.41%449.98 M USD
2982
OCGN
Ocugen, Inc. - Common Stock
1.32 USD-0.75%-7.04%+6.45%+30.69%447.63 M USD